The shares of the real estate company jumped up to 2 percent after receiving a work order from Tridhaatu Aranya Developers for a total contract value of Rs. 101 Crores. The shares have given more than 60 percent return to its shareholders on a YTD basis.
With a market capitalization of Rs. 1,884 crores, the shares of Capacit’e Infraprojects Ltd started Wednesday’s trading session on a higher note at Rs. 261 compared to its previous close at Rs. 259. The share hit a high of Rs. 264 making a gain of around 2 percent, and currently trading at Rs. 256 apiece.
Such a positive movement was observed after the company in an exchange filing mentioned that they had received a work order from Tridhaatu Aranya Developers for a total contract value of Rs. 101 Crores for a project (Aranya Phase-II at Chembur). This is a repeated order from Tridhaatu. The Company has also executed its Project-Aranya Phase 1.
Coming on to the Financial statement, the revenue decreased by 1.8 percent from Rs. 430 crores during the June quarter to Rs. 422 crores in the September quarter. On a contrasting note, the net profit increased by 5 percent from Rs. 19 crores to Rs. 20 crores during the same timeframe.
Looking at the important financial ratios, the return on equity (RoE) increased from 5.04 percent in FY21-22 to 9.41 FY22-23 percent and the return on capital employed (RoCE) improved from 10.53 percent to 16.49 during the same period.
According to the latest shareholding pattern, the Promoters have a 35.67 percent stake in which they have pledged around 28.59 percent, the Public or Retail Investors have 47.93 percent holdings, DIIs have 8.13 percent stake, and the remaining 8.13 are with FIIs.
Headquartered in Mumbai, Capacit’e Infraprojects Ltd was incorporated in 2012. The company is engaged in engineering, procurement, and construction. The company provides end-to-end building construction services with a portfolio comprising residential projects, commercial office buildings, such as data centers, and buildings for educational, hospitality, and healthcare purposes.
Written By Vaibhav Patil
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
